Stock Market Recap: Inovio Pharmaceuticals Inc (INO) Concludes at 5.15, a -3.56 Surge/Decline

Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $5.34 in the prior trading day, Inovio Pharmaceuticals Inc (NASDAQ: INO) closed at $5.15, down -3.56%. In other words, the price has decreased by -$3.56 from its previous closing price. On the day, 0.56 million shares were traded. INO stock price reached its highest trading level at $5.3981 during the session, while it also had its lowest trading level at $5.1.

Ratios:

Our goal is to gain a better understanding of INO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 4.45. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on May 14, 2024, initiated with a Overweight rating and assigned the stock a target price of $20.

On January 25, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $4.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INO now has a Market Capitalization of 133716144 and an Enterprise Value of 36274672. For the stock, the TTM Price-to-Sale (P/S) ratio is 226.64 while its Price-to-Book (P/B) ratio in mrq is 1.38. Its current Enterprise Value per Revenue stands at 61.289 whereas that against EBITDA is -0.315.

Stock Price History:

Over the past 52 weeks, INO has reached a high of $14.75, while it has fallen to a 52-week low of $4.03. The 50-Day Moving Average of the stock is -12.10%, while the 200-Day Moving Average is calculated to be -40.68%.

Shares Statistics:

The stock has traded on average 292.22K shares per day over the past 3-months and 293520 shares per day over the last 10 days, according to various share statistics. A total of 25.96M shares are outstanding, with a floating share count of 25.74M. Insiders hold about 0.85% of the company’s shares, while institutions hold 31.36% stake in the company. Shares short for INO as of 1728950400 were 3476286 with a Short Ratio of 11.99, compared to 1726185600 on 3050539. Therefore, it implies a Short% of Shares Outstanding of 3476286 and a Short% of Float of 13.48.

Most Popular